Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN107,9108,2-1,92
Msft-0,13
Nokia5,8665,921,16
IBM1,10
Mercedes-Benz Group AG57,5857,60,89
PFE0,40
14.02.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026 22:00:00
Movano Rg (NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (USD)
11,77 -5,69 -0,71 406 877
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 14.02.2026
Popis společnosti
Obecné informace
Název společnostiMovano Inc
TickerMOVE
Kmenové akcie:Ordinary Shares
RICMOVE.O
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.09.2025
Počet zaměstnanců k 31.12.2024 32
Akcie v oběhu k 10.11.2025 834 857
MěnaUSD
Kontaktní informace
Ulice6800 Koll Center Parkway
MěstoPLEASANTON
PSČ94566
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon14 156 513 172
Fax13026365454

Business Summary: Movano Inc., doing business as Movano Health, is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade data to the forefront of consumer health devices. Its commercial product Evie Ring is a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one’s health, which includes resting heart rate, heart rate variability, blood oxygen saturation, respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. The Company is also developing a proprietary System-on-a-Chip (SoC) designed for blood pressure or continuous glucose monitoring systems. This data is delivered through a mobile app which simplifies how data is presented and turns biometric data into actionable insights that help women make manageable lifestyle changes.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Movano Inc revenues decreased 57% to $389K. Net loss decreased 35% to $12.4M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects ELECTROMEDICAL segment loss decrease of 43% to $11.1M. Basic Earnings per Share excluding Extraordinary Items decreased from -$3.52 to -$5.87.
Odvětvová klasifikace
TRBC2012Advanced Medical Equipment & Technology (NEC)
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
NAICS2007Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
NAICS1997Research and Development in the Physical, Engineering, and Life Sciences
SICCommercial Physical Research



  • Poslední aktualizace: 14.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, DirectorJohn Mastrototaro6501.04.202101.04.2021
Founder, Chief Technology Officer, DirectorMichael Leabman5201.04.2021
Chief Financial OfficerJeremy Cogan56